The Lm-TRP2-NP vaccine was also found to be therapeutically effective against B16-MO5 metastatic lesions, a variant of the B16 tumor cell line stably expressing chicken ovalbumin (Falo et al., 1995). Here, DCT is linked to neoplasm.